| 영문 | Buerger disease | 한글 | 버거병 |
|---|---|---|---|
| 설명 | 말초 동맥과 정맥에 염증을 일으키는 병. 청장년층의 남자에게 잘 걸리는 다리 동맥에 생기는 병으로 동맥이 막히고 통증 때문에 발을 절기도 하는데 원인은 알려져 있지 않다. 병명은 이 병을 최초로 상세하게 보고한 미국의 의사 L. 버거(1879~1943)의 이름에서 연유한다. 동양인에게 많은 병으로, 대부분 젊은 남성, 특히 장년기 남성에게서 나타난다. 원인은 알 수 없으나 흡연이 병의 악화를 초래한다. 사지의 동맥과 정맥에 염증이 일어나 혈전이 생기면 내강을 막아 혈액이 흐르지 못하게 되어 그 앞의 말초조직이 괴사에 빠지거나 손발이 차갑고, 손가락-발가락이 보라색 또는 검은색으로 변한다. 또, 이 증세가 계속되는 동안 손발가락에 통증이 일어나고 궤양이 발생한다. 치료는 증세의 정도와 폐색된 혈관의 부위에 따라 연고를 바르거나 혈관확장제-순환개선제-혈소판응집억제제를 사용하나, 어떤 치료도 효과가 없을 경우 손발가락의 소절단, 드물게는 무릎 이하의 대절단을 해야 한다. 일반적으로 이 병의 예후는 양호하여 혈류가 회복되고 궤양만 치료되면 재발이 적다. |
||
| 영문 | Behcet disease | 한글 | 베체트병 |
|---|---|---|---|
| 설명 | 심한 포도막염, 망막혈관염, 시각신경위축, 구강-성기의 아프타성 궤양, 광범위한 혈관염의 징후와 증상을 나타낸다. 원인불명의 희귀한 병으로 젊은 남자에게 잘 발생한다. |
||
| 영문 | congenital heart disease | 한글 | 선천심장병 |
|---|---|---|---|
| 설명 | 선천적으로 심장의 구조에 이상이 있는 병. |
||
| 영문 | venereal disease, sexually transmitted diseases | 한글 | 성병 |
|---|---|---|---|
| 설명 | 보편적으로 성교 또는 성기접촉에 의해 걸리는 접촉 전염병으로 매독, 임질, 무른궤양, 샅굴육아종 등을 말한다. 치료는 원인균에 따른 적절한 항생요법이다. |
||
| 영문 | VDRL(venereal disease research laboratory) | 한글 | 성병 연구실험실 |
|---|---|---|---|
| 설명 | 매독균의 reagin에 대한 항체. 매독의 선별검사로 사용되며 매독 치료에 대한 반응 여부와 치료효과 판정에도 사용된다. 매독외에도 전신성홍반성낭창, 류마티스관절염 등에서도 양성으로 나타날 수 있다. |
||
| AHD | acquired hepatocerebral degeneration; acute heart disease; antihyaluronidase; antihypertensive drug;... |
|---|---|
| ARD | absolute reaction of degeneration; acute radiation disease; acute respiratory disease; adult respira... |
| DD | dangerous drug; data definition; day of delivery; degenerated disc; degenerative disease; delusional... |
| DDD | AV universal [pacemaker]; defined daily dose; degenerative disc disease; dehydroxydinaphthyl disulfi... |
| ND | Doctor of Naturopathy; nasal deformity; natural death; Naval Dispensary; neonatal death; neoplastic ... |
| amygdalin beta(1-6)glucosidase | <enzyme> Forms prunasin and glucose Registry number: EC 3.2.1.- Synonym: laetrile glucosidase, amygdalin hydrolase I, amygdalin hydrolase II (26 Jun 1999) |
|---|---|
| amyloid beta-protein | A 4 kD protein, 39-43 amino acids long, expressed by a gene located on chromosome 21. It is the major protein subunit of the vascular and plaque amyloid filaments in individuals with alzheimer's disease and in aged individuals with trisomy 21 (down syndrome). The protein is found predominantly in the nervous system, but there have been reports of its presence in non-neural tissue. (12 Dec 1998) |
| amyloid beta-protein precursor | A precursor to the amyloid-beta protein (beta/a4). Alterations in the expression of the amyloid beta-protein precursor (abpp) gene, located on chromosome 21, plays a role in the development of the neuropathology common to both alzheimer disease and down syndrome. Abpp is associated with the extensive extracellular matrix secreted by neuronal cells. Upon cleavage, this precursor produces three proteins of varying amino acid lengths: 695, 751, and 770. The beta/a4 (695 amino acids) or beta-amyloid protein is the principal component of the extracellular amyloid in senile plaques found in alzheimer disease, down syndrome and, to a limited extent, in normal aging. (12 Dec 1998) |
| androst-16-en-3 beta-ol sulfotransferase | <enzyme> A beta sulfotransferase Registry number: EC 2.8.2.- Synonym: aebo sulfotransferase (26 Jun 1999) |
| androsta-5,16-dien-3 beta-ol synthetase | <enzyme> Nadph- and o(2)-dependent; converts progesterone to 4,16-androstadien-3-one and converts pregnenolone to androstadienol Registry number: EC 1.- Synonym: pregnenolone side-chain cleavage enzyme, 5,16-androstadien-3 beta-ol synthetase, 5,16-androstadien-3-ol synthase, 4,16-androstadien-3-one synthesizing enzyme, 4,16-adien-3-one synthase, 4,16-ado synthase, delta(16)-c(19)-steroid synthetase, andien-beta-synthetase, 16-ene-synthetase (26 Jun 1999) |
| beta | Entry pre fix is generally ignored for alphabetical reference, look for main portion of word. (18 Nov 1997) |
| beta (1)-anticollagenase | <chemical> A serum protein inhibitor (26 Jun 1999) |
| beta-(2-furyl)-acryloyl phosphate hydrolase | <enzyme> Used as synthetic substrate for atpase assay Registry number: EC 3.6.1.- Synonym: bfa phosphatase (26 Jun 1999) |
| beta 2-microglobulin | An 11 kD protein associated with the outer membrane of many cells including lymphocytes. It is the small subunit of the MHC class I molecule. Association with beta 2-microglobulin is generally required for the transport of class I heavy chains from the endoplasmic reticulum to the cell surface. Beta 2-microglobulin is present in small amounts in serum, csf, and urine of normal people, and to a much greater degree in the urine and plasma of patients with tubular proteinaemia, renal failure, or kidney transplants. (12 Dec 1998) |
| beta-adrenergic blocking agent | A class of drugs that compete with beta-adrenergic agonists for available receptor sites; some compete for both b1 and b2 receptors (e.g., propranolol) while others are primarily either b1 (e.g., metoprolol) or b2 blockers; used in the treatment of a variety of cardiovascular diseases where beta-adrenergic blockade is desirable. Synonym: beta-adrenergic receptor blocking agent, beta-adrenoreceptor antagonist, beta-blocker. (05 Mar 2000) |
| beta-adrenergic receptor blocking agent | A class of drugs that compete with beta-adrenergic agonists for available receptor sites; some compete for both b1 and b2 receptors (e.g., propranolol) while others are primarily either b1 (e.g., metoprolol) or b2 blockers; used in the treatment of a variety of cardiovascular diseases where beta-adrenergic blockade is desirable. Synonym: beta-adrenergic receptor blocking agent, beta-adrenoreceptor antagonist, beta-blocker. (05 Mar 2000) |
| beta-adrenergic receptor kinase | <enzyme> Cyclic-AMP protein kinase which specifically phosphorylates the agonist-occupied form of beta-adrenergic receptor Registry number: EC 2.7.1.- Synonym: beta-ar kinase, beta-adrenergic receptor kinase 1, g-protein-coupled receptor kinase 2, grk2 (kinase), beta-adrenergic receptor kinase 2, beta-ar kinase 2 (26 Jun 1999) |
| beta-adrenergic receptors | Adrenergic receptor's in effector tissues capable of selective activation and blockade by drugs; conceptually derived from the ability of certain agents, such as propranolol, to block only some adrenergic receptor's and of other agents, such as isoproterenol, to activate only the same adrenergic receptor's. Such receptor's are designated as beta-receptors. Their activation results in physiological responses such as increases in cardiac rate and force of contraction (b1), and relaxation of bronchial and vascular smooth muscle (b2). (05 Mar 2000) |
| beta-adrenoreceptor antagonist | A class of drugs that compete with beta-adrenergic agonists for available receptor sites; some compete for both b1 and b2 receptors (e.g., propranolol) while others are primarily either b1 (e.g., metoprolol) or b2 blockers; used in the treatment of a variety of cardiovascular diseases where beta-adrenergic blockade is desirable. Synonym: beta-adrenergic receptor blocking agent, beta-adrenoreceptor antagonist, beta-blocker. (05 Mar 2000) |
| beta-alanine | <chemical> Beta-alanine. An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing gaba. A rare genetic disorder, hyper-beta-alaninaemia, has been reported. Chemical name: beta-Alanine (12 Dec 1998) |